Log in | Register

Gov. visits medical marijuana clinic in Missoula

For the latest pharmaceutical news and updates - Sign up now!
Loading...

During his first visit to a medical marijuana clinic, Gov. Brian Schweitzer reaffirmed his support for the industry Thursday while repeating his view that new legislation governing it is imminent and necessary.

The governor met with Rick Rosio, president and CEO of Missoula's Montana Pain Management, and heard about the challenges facing professional medical marijuana caregivers in Montana.

Rosio said the lack of regulation and standardized business practices hurts his business as much as it worries those who are unfamiliar with the applications and benefits of medical marijuana.

"If I sold hot dogs, I could go down and get a line of credit" from a commercial lender, he said. "With the cash flow I have, we could show the ability to generate tremendous revenue. But none of the financial institutions will work with us on a credit line because they don't understand the business."

Rosio also portrayed his business as a legitimate operation, pointing out that he pays taxes and noting his business has been acquired by Cannabis Science Inc., a publicly traded company based in Colorado Springs, Colo.

Schweitzer said earlier this month legalization of medical marijuana has not worked out as voters planned and the state needs a legislative fix. His comments were spurred by his belief that there are some in Montana who are smoking medical marijuana even if they don't need it.

"I think it's unrealistic to say to legitimate medical patients that have found benefit from medical marijuana that you can no longer access this," Schweitzer said. "I think we need to tighten up the laws. ... The business has gotten out ahead of the regulatory environment and we need to build some boundaries."

Schweitzer and Rosio agreed that the number of independent, commercial growers should be limited, and that taxing medical marijuana is probably necessary to pay for increased regulation.

___

Information from: Missoulian, http://www.missoulian.com


Join the Discussion
Rate Article:  Average 5 out of 5
register or log in to comment on this article!

1 Comments

  • Having the distinct honor to spend time with Governor Schweitzer discussing the medical cannabis issue in Montana I would like to propose that those of you who recognize the scientific data that is available(other than NIDA's sponsored studies) and open the discussion on how to implement this alternative analgesic and it's benefits in long term application when trying to replace narcotics in palliative care patients.
    While many states are coming to terms with the new application for cannabis in treating the sick, Montana Pain Management has been acquired by Cannabis Science Inc to allow for a scientific approach to the development of this important new application in the medical arsenal.
    Rick Rosio
    Montana Pain Management a division of
    Cannabis Science INC

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

When Is Software The Answer To Regulatory Concerns About Your Investigations?

When Is Software The Answer To Regulatory Concerns About Your Investigations?

Jan 30 | John Ager, Technical Consultant, Life Science, Kepner-Tregoe, Inc

Document management software enables investigators to present the information used to reach conclusions clearly and concisely and it helps reviewers to track and approve investigations.

The Benefits of Professional Project Management

The Benefits of Professional Project Management

Jan 13 | Thorsten Vammen, Director at GEA Liquid Processing in Skanderborg, Denmark

Some companies feel that they can project manage new processing facilities themselves, bringing in sub-contracted help only when it’s needed. Self-managing is possible, but there may be a better way.

Multimedia

Government Seeking $1T Campaign Against Alzheimer's

Government Seeking $1T Campaign Against Alzheimer's

Jan 18 | Video

Government advisors tried to set priorities for a national campaign to treat and manage Alzheimer's disease, which is projected to cost more than a trillion dollars in care by 2050. But as Dr. Jon LaPook reports, the plan does not include any funding.

ADHD Drugs in Short Supply

ADHD Drugs in Short Supply

Jan 11 | Video

Parents of children with attention deficit disorders are forced to travel from pharmacy to pharmacy in search of prescription medicines with no guarantees they will be available.

Study: Link Between Statins And Diabetes

Study: Link Between Statins And Diabetes

Jan 10 | Video

A recent study reveals that women who take statins may have a greate chance of developing diabetes.

Avastin Shows Promise in Fight Against Ovarian Cancer

Avastin Shows Promise in Fight Against Ovarian Cancer

Jan 5 | Video

Two recent studies show that Avastin, already approved for other cancers - but still controversial, could help women buy more time in their fight against ovarian cancer.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter